Tuesday, 11 July 2017

Breast Cancer and Pregnancy: Experience of Maternity and Neonatology Center of Tunis-Tunisia

This document aims to identify the clinical, therapeutic, and prognostic features of this association and to provide the up-to-date management.

Breast Cancer

Our study design is retrospective based on 25 cases of pregnancy-associated breast cancer, carried out at the Maternity and Neonatology Center of Tunis over a period of 10 years, between January 2001 and December 2013.

The mean age of the patients was 35.84 years. Breast cancer was diagnosed during pregnancy in fourteen patients and after delivery in eleven patients. Pathohistological diagnosis was established by ultrasoundguided biopsy and surgical biopsy in fourteen and seven patients, respectively.


Monday, 10 July 2017

The Hematologic Toxicity of Methotrexate in Patients with Autoimmune Disorders

Hematologic Toxicity of Methotrexate

The incidence of auto-immune diseases is increasing nowa- days. Despite of the development of diagnosis and management of diseases, they remained chronic diseases.

The patient’s lifespan expansion requires long-term treatment with harmful agents, such as Methotrexate or other immuno-suppressive drugs. The Methotrexate toxicities are based on the duration and cumulative dosing of drug, and the combination with other drugs.

Myelosuppression and consequent pancytopenia is the most frequent hematologic toxicity, which occur mostly later during low dose methotrexate administration. We demonstrate three cases of low dose Methotrexate toxicity in older patients with rheumatoid arthritis and psoriasis.

Thursday, 6 July 2017

Misdiagnosis of Groove Pancreatitis: A Case Report

Groove PancreatitisGroove Pancreatitis (GP) is a kind of chronic pancreatitis with a clear pathological diagnosis. It’s characterized by fibrotic scarring of the gastroduodenal groove, an anatomical area near the pancreatic head, duodenum and common bile duct (CBD).

Its etiology is not clear. GP may be related to alcoholism, weight loss, biliary tract disease, pancreatic cysts and so on. Its incidence rate of GP is low and the diagnosis is difficult.

The purpose of this essay is to report a case of GP. A 56-year-old woman is admitted to hospital with painless systemic jaundice as her only symptom and the symptom aggravated in two months.

Tuesday, 4 July 2017

Adjuvant Chemoradiation for Localized Gastric Adenocarcinoma: An Institutional Experience

Adjuvant Chemoradiation
cancer with locoregional relapse in 40% to 60%. The frequency of relapses makes regional radiotherapy an attractive possibility for adjuvant therapy. The survival benefit of adjuvant chemoradiation over surgery alone was first established by the US Intergroup 0116 study.

Between January 2010 and December 2014, 48 patients with localized gastric adenocarcinoma, managed at radiotherapy department of the national institut of oncology, they underwent adjuvant chemoradiation according the classical MacDonald regimen.

This series consisted of non-metastatic patients, 68.8% (33) males with a mean age 51 years. 20.8% (10) of patients had relapses (all distant relapse). 22 (45.8%) patients died, only 8(16.6%) patients were lost to follow up.

Friday, 30 June 2017

Advanced Radiotherapy Techniques to Reduce Mortality and Morbidity in Cervical Cancer

Radiotherapy Techniques
Cervical cancer is the 4th major killer of the women worldwide. Despite primary and advanced medical care and awareness levels in most part of the developed worlds, the mortality remained very high till date.

If it is localized at the time of diagnosis, the five year survival rate would by 61% in UK and if it is in the metastatic, it guarantees only 44% survival rate. Chemotherapy, followed by the radio therapy is the usual treatment procedure for the cervical cancer. Yet it could not reduce the mortality and morbidity and it is leading to hematologic toxicity, the radiation is also affecting the health cells in the body.

Intensity Modulated Radiotherapy (IMRT) and image guided brachytherapy (IGBT) are the recent advancements, capable of strictly confining to the target area. Exciting therapeutic and pharmacological methods are ensuring the improved survival rates due to effective treatment procedures.

Thursday, 29 June 2017

Molecular Targets in Lung Cancer Therapy: A Current Review

Cancer incidence worldwide has been increasing over the years. Lung cancer (LC) is a disease with a poor prognosis once diagnosed. LC is the leading cause of death in men worldwide and the second cause of mortality in women . In Portugal, LC remains as the leading cause of deathdue cancer in men. 

Lung Cancer

LC origins from oncogenic alterations in tissues from the respiratory epithelium, namely in bronchi, bronchioles and alveoli. This cancer results from multiple morphological, molecular and genetic changes, leading to an accumulation of malignant cells. LC is mainly classified into two categories, according to its histological characteristics: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is categorized into three different categories, namely adenocarcinoma, squamous cell carcinoma and large cell carcinoma.  Read More>>>>>>

Wednesday, 28 June 2017

Exceptional Therapeutic Outcome of Metastatic Neuroendocrine Tumor with Peptide Receptor Radionuclide Therapy with Brief Review of Literature

neuroendocrine tumor
NETs are rare, heterogeneous group of neoplasm presented as chronic oncologic disease. Somatostatin analogue is the standard first line systemic therapy for mainly hormone control.

No standard second line systemic treatment is available except everolimus which has no reported complete response.

PRRT is an innovative molecular targeted treatment based on theragnostic concept for well differentiated NETs. We presented here a 63-year-old lady with grade 1 NET of rectum with lymphnodal and liver metastasis.